| Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma J Okosun, C Bödör, J Wang, S Araf, CY Yang, C Pan, S Boller, D Cittaro, ... Nature genetics 46 (2), 176-181, 2014 | 754 | 2014 |
| EZH2 mutations are frequent and represent an early event in follicular lymphoma C Bödör, V Grossmann, N Popov, J Okosun, C O’Riain, K Tan, J Marzec, ... Blood, The Journal of the American Society of Hematology 122 (18), 3165-3168, 2013 | 352 | 2013 |
| Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma J Okosun, RL Wolfson, J Wang, S Araf, L Wilkins, BM Castellano, ... Nature genetics 48 (2), 183-188, 2016 | 232 | 2016 |
| Disease evolution and outcomes in familial AML with germline CEBPA mutations K Tawana, J Wang, A Renneville, C Bödör, R Hills, C Loveday, A Savic, ... Blood, The Journal of the American Society of Hematology 126 (10), 1214-1223, 2015 | 208 | 2015 |
| EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors RE White, PC Rämer, KN Naresh, S Meixlsperger, L Pinaud, C Rooney, ... The Journal of clinical investigation 122 (4), 2012 | 188 | 2012 |
| EZH2 Y641 mutations in follicular lymphoma C Bödör, C O'riain, D Wrench, J Matthews, S Iyengar, H Tayyib, ... Leukemia 25 (4), 726-729, 2011 | 175 | 2011 |
| P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse S Iyengar, A Clear, C Bödör, L Maharaj, A Lee, M Calaminici, J Matthews, ... Blood, The Journal of the American Society of Hematology 121 (12), 2274-2284, 2013 | 150 | 2013 |
| Germ-line GATA2 p. THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival C Bödör, A Renneville, M Smith, A Charazac, S Iqbal, P Étancelin, ... haematologica 97 (6), 890, 2012 | 121 | 2012 |
| Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL A Agathangelidis, A Chatzidimitriou, K Gemenetzi, V Giudicelli, ... Blood, The Journal of the American Society of Hematology 137 (10), 1365-1376, 2021 | 106 | 2021 |
| Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration K Dezső, P Jelnes, V László, K Baghy, C Bödör, S Paku, N Tygstrup, ... The American journal of pathology 171 (5), 1529-1537, 2007 | 105 | 2007 |
| The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants A Rio-Machin, T Vulliamy, N Hug, A Walne, K Tawana, S Cardoso, ... Nature communications 11 (1), 1044, 2020 | 92 | 2020 |
| ROR1 expression is not a unique marker of CLL G Barna, R Mihalik, B Timár, J Tömböl, Z Csende, A Sebestyén, C Bödör, ... Hematological oncology 29 (1), 17-21, 2011 | 92 | 2011 |
| Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant … L Reiniger, C Bödör, A Bognar, Z Balogh, J Csomor, A Szepesi, L Kopper, ... Leukemia 20 (6), 1089-1095, 2006 | 82 | 2006 |
| Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL AF Rendeiro, T Krausgruber, N Fortelny, F Zhao, T Penz, M Farlik, ... Nature Communications 11 (1), 577, 2020 | 81 | 2020 |
| GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations CL Green, K Tawana, RK Hills, C Bödör, J Fitzgibbon, S Inglott, P Ancliff, ... British journal of haematology 161 (5), 701-705, 2013 | 71 | 2013 |
| GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML AF Al Seraihi, A Rio-Machin, K Tawana, C Bödör, J Wang, A Nagano, ... Leukemia 32 (11), 2502-2507, 2018 | 67 | 2018 |
| Clonal selection in the bone marrow involvement of follicular lymphoma A Bognar, B Csernus, C Bödör, L Reiniger, A Szepesi, E Toth, L Kopper, ... Leukemia 19 (9), 1656-1662, 2005 | 54 | 2005 |
| Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib A Gángó, D Alpár, B Galik, D Marosvári, R Kiss, V Fésüs, D Aczél, ... International Journal of Cancer 146 (1), 85-93, 2020 | 53 | 2020 |
| Structural analysis of oval‐cell–mediated liver regeneration in rats K Dezső, V Papp, E Bugyik, H Hegyesi, G Sáfrány, C Bödör, P Nagy, ... Hepatology 56 (4), 1457-1467, 2012 | 52 | 2012 |
| Aberrant somatic hypermutation and expression of activation‐induced cytidine deaminase mRNA in mediastinal large B‐cell lymphoma C Bödör, A Bognár, L Reiniger, A Szepesi, E Toth, L Kopper, A Matolcsy British journal of haematology 129 (3), 373-376, 2005 | 47 | 2005 |
András MatolcsyProfessor of Pathology, Semmelweis UniversityVerified email at korb1.sote.hu
